We also performed IHC staining on whole-tumor slides of our discovery cohort to quantify densities of CD8+ tumor-infiltrated lymphocytes (TILs), the main factor in antitumor immunity and an indicator of immunotherapy efficacy (38). This evidence concerns the gene CD8A and neoplasm.